Cagrilintide works through the amylin pathway, offering a different mechanism entirely
Can J Diabetes 2020;44:575-91
Reference List Bariendo
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases
Why I Am Requesting an Exception: Obesity Is a Chronic Disease With Serious Health Consequences Obesity is widely recognized by the medical community as a chronic, progressive disease associated with increased risk of cardiovascular disease, type 2 diabetes, stroke, certain cancers, sleep apnea, and other serious conditions
On the other hand, there has been a sharp uptick in prescriptions of GLP-1 RAs for weight loss with little oversight